189 related articles for article (PubMed ID: 30482401)
1. Blastic plasmacytoid dendritic cell neoplasm with immunoblastoid morphology and MYC rearrangement and overexpression.
Chang KC; Yu-Yun Lee J; Sakamoto K; Baba S; Takeuchi K
Pathology; 2019 Jan; 51(1):100-102. PubMed ID: 30482401
[No Abstract] [Full Text] [Related]
2. Meningeal spread of blastic plasmacytoid dendritic cell neoplasm.
Starck M; Zewen S; Eigler A; Wendtner CM
Eur J Haematol; 2014 Aug; 93(2):175-6. PubMed ID: 24483771
[No Abstract] [Full Text] [Related]
3. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
[TBL] [Abstract][Full Text] [Related]
4. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
5. Immunoblastoid blastic plasmacytoid dendritic cell neoplasm with MYC rearrangement.
Yu YT; Chang KC
Blood; 2022 Apr; 139(14):2257. PubMed ID: 35389436
[No Abstract] [Full Text] [Related]
6. Yu Y-T, Chang K-C. Immunoblastoid blastic plasmacytoid dendritic cell neoplasm with MYC rearrangement. Blood. 2022;139(14):2257.
Blood; 2023 Feb; 141(6):682. PubMed ID: 36757725
[No Abstract] [Full Text] [Related]
7. Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm: Chromosomal Rearrangements and DNA Copy-Number Alterations.
Sakamoto K; Takeuchi K
Hematol Oncol Clin North Am; 2020 Jun; 34(3):523-538. PubMed ID: 32336417
[TBL] [Abstract][Full Text] [Related]
8. Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate.
Arranto C; Tzankov A; Halter J
Ann Hematol; 2017 Apr; 96(4):681-682. PubMed ID: 28013360
[No Abstract] [Full Text] [Related]
9. Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases.
Griffin JC; Aqel N; Siow W; Camilleri M; Ayto R
Ann Hematol; 2017 Oct; 96(10):1769-1770. PubMed ID: 28762083
[No Abstract] [Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review.
Espasa A; Sorigue M; Tapia G; Cabezon M; Vergara S; Raya M; Navarro JT; Junca J; Zamora L; Xicoy B
Cytometry B Clin Cytom; 2021 May; 100(3):292-295. PubMed ID: 32830878
[No Abstract] [Full Text] [Related]
12. Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm.
Suzuki K; Suzuki Y; Hama A; Muramatsu H; Nakatochi M; Gunji M; Ichikawa D; Hamada M; Taniguchi R; Kataoka S; Murakami N; Kojima D; Sekiya Y; Nishikawa E; Kawashima N; Narita A; Nishio N; Nakazawa Y; Iwafuchi H; Watanabe KI; Takahashi Y; Ito M; Kojima S; Kato S; Okuno Y
Leukemia; 2017 Jul; 31(7):1629-1633. PubMed ID: 28344318
[No Abstract] [Full Text] [Related]
13. Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm.
Schwede M; Tan IT; Atibalentja DF; Dickman MM; Rieger KE; Mannis GN
Ann Hematol; 2020 Dec; 99(12):2973-2975. PubMed ID: 32968828
[No Abstract] [Full Text] [Related]
14. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm with centrocyte-like morphology clinically simulating a melanocytic nevus.
Chu C; Rudnick EW; Motaparthi K
J Cutan Pathol; 2018 Apr; 45(4):249-253. PubMed ID: 29293270
[No Abstract] [Full Text] [Related]
17. Two rare cases of blastic plasmacytoid dendritic cell neoplasm and a literature review.
Chu G; Verner E; Lee K; Painter V; Fletcher J; Curnow J
Leuk Lymphoma; 2014 Oct; 55(10):2405-7. PubMed ID: 24432892
[No Abstract] [Full Text] [Related]
18. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.
Hashikawa K; Niino D; Yasumoto S; Nakama T; Kiyasu J; Sato K; Kimura Y; Takeuchi M; Sugita Y; Hashimoto T; Ohshima K
J Am Acad Dermatol; 2012 Feb; 66(2):278-91. PubMed ID: 21835496
[TBL] [Abstract][Full Text] [Related]
19. Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases.
Khwaja R; Daly A; Wong M; Mahé E; Cerquozzi S; Owen C
Leuk Lymphoma; 2016 Nov; 57(11):2720-2. PubMed ID: 26984056
[No Abstract] [Full Text] [Related]
20. A large mass and erythematous-violaceous plaques.
Pileri A; Agostinelli C; Barisani A; Patrizi A; La Placa M
J Dtsch Dermatol Ges; 2018 Mar; 16(3):372-375. PubMed ID: 29465828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
